Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy.
Journal
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
2
6
2020
pubmed:
2
6
2020
medline:
2
6
2020
Statut:
epublish
Résumé
[This corrects the article DOI: 10.1186/s13223-020-00419-z.].
Identifiants
pubmed: 32477416
doi: 10.1186/s13223-020-00435-z
pii: 435
pmc: PMC7240927
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
38Commentaires et corrections
Type : ErratumFor
Informations de copyright
© The Author(s) 2020.
Références
Allergy Asthma Clin Immunol. 2020 Apr 17;16:25
pubmed: 32328115